Table 2.

Antibiotic Treatment of Patients with BP Eliminates Lesional Staphylococcus aureus Colonization and Is Associated with a Reduction in Disease Severity

Patient ID	Sex/Age (y)	Before Referral1 (Drug, Daily Dose, Duration)	After Enrollment (Drug, Daily Dose)	BPDAI2 Enrollment/Follow-Up (Days Elapsed)	% Decline BPDAI3
758	M/67.2	Prednisone, 60 mg, 39 d; Mycophenolate, 3 g, 39 d	Prednisone, 40 mg; Clindamycin, 1.35 g; Mycophenolate, 1g	173/97 (23)	44
781	F/61.5	Triamcinalone, 0.1% ointment	Clindamycin, 1.35 g	92/44 (25)	52
703	F/87.1	Betamethasone, 0.05% ointment	Doxycycline, 200 mg	59/50 (21)	15
807	M/74.3	Triamcinalone, 0.1% ointment	Doxycycline, 200 mg	43/37 (27)	14

Abbreviations: BP, bullous pemphigoid; BPDAI, Bullous Pemphigoid Disease Area Index; F, female; ID, identification; M, male.

S. aureus was isolated from lesional swabs obtained from patients with BP on the date of enrollment.

¹Medications prescribed by the referring physician before their initial visit to University of Iowa Hospitals & Clinics.

²Disease severity was scored using the BPDAI on the date of enrollment and at the next routine visit; the number of days elapsed is indicated in the parentheses.

³The percentage decline in BPDAI = (BPDAI enrollment / [BPDAI at enrollment − BPDAI at follow-up]) × 100.